Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2012, Article ID 945608, 8 pages
http://dx.doi.org/10.1155/2012/945608
Research Article

Arginine 16 Glycine Polymorphism in β2-Adrenergic Receptor Gene Is Associated with Obesity, Hyperlipidemia, Hyperleptinemia, and Insulin Resistance in Saudis

1Department of Zoology, Female Center for Scientific and Medical Colleges, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia
2Department of Genetics, King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia
3Department of Biochemistry, Female Center for Scientific and Medical Colleges, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia
4Department of Obstetrics and Gynecology, Umm Al-Qura University, P.O. Box 424, Makkah 21955, Saudi Arabia
5Department of Biostatistics, Epidemiology & Scientific Computing, King Faisal Specialist Hospital and Research Center MBC 03, P.O. Box 3354, Riyadh 11211, Saudi Arabia

Received 6 May 2012; Revised 27 July 2012; Accepted 24 August 2012

Academic Editor: Daniela Jezova

Copyright © 2012 Maha H. Daghestani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Bouchard, “Current understanding of the etiology of obesity: genetic and nongenetic factors,” American Journal of Clinical Nutrition, vol. 53, no. 6, pp. 1561–1565, 1991. View at Google Scholar · View at Scopus
  2. B. M. Spiegelman and J. S. Flier, “Adipogenesis and obesity: rounding out the big picture,” Cell, vol. 87, no. 3, pp. 377–389, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Rankinen, A. Zuberi, Y. C. Chagnon et al., “The human obesity gene map: the 2005 update,” Obesity, vol. 14, no. 4, pp. 529–644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Lafontan and M. Berlan, “Fat cell adrenergic receptors and the control of white and brown fat cell function,” Journal of Lipid Research, vol. 34, no. 7, pp. 1057–1091, 1993. View at Google Scholar · View at Scopus
  5. F. Lonnqvist, H. Wahrenberg, L. Hellstrom, S. Reynisdottir, and P. Arner, “Lipolytic catecholamine resistance due to decreased β2-adrenoceptor expression in fat cells,” Journal of Clinical Investigation, vol. 90, no. 6, pp. 2175–2186, 1992. View at Google Scholar · View at Scopus
  6. S. Enocksson, M. Shimizu, F. Lonnqvist, J. Nordenstrom, and P. Arner, “Demonstration of an in vivo functional β3-adrenoceptor in man,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2239–2245, 1995. View at Google Scholar · View at Scopus
  7. P. Barbe, L. Millet, J. Galitzky, M. Lafontan, and M. Berlan, “In situ assessment of the role of the β1-, β2- and β3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue,” British Journal of Pharmacology, vol. 117, no. 5, pp. 907–913, 1996. View at Google Scholar · View at Scopus
  8. S. A. Green, J. Turki, I. P. Hall, and S. B. Liggett, “Implications of genetic variability of human β2-adrenergic receptor structure,” Pulmonary Pharmacology, vol. 8, no. 1, pp. 1–10, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. S. B. Liggett, “Pharmacogenetics of beta-1- and beta-2-adrenergic receptors,” Pharmacology, vol. 61, no. 3, pp. 167–173, 2000. View at Google Scholar · View at Scopus
  10. S. A. Green, J. Turki, M. Innis, and S. B. Liggett, “Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties,” Biochemistry, vol. 33, no. 32, pp. 9414–9419, 1994. View at Google Scholar · View at Scopus
  11. S. A. Green, G. Cole, M. Jacinto, M. Innis, and S. B. Liggett, “A polymorphism of the human β2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor,” Journal of Biological Chemistry, vol. 268, no. 31, pp. 23116–23121, 1993. View at Google Scholar · View at Scopus
  12. S. Ishiyama-Shigemoto, K. Yamada, X. Yuan, F. Ichikawa, and K. Nonaka, “Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus,” Diabetologia, vol. 42, no. 1, pp. 98–101, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Iwamoto, Y. Ogawa, S. Kajihara et al., “Gln27Glu β2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver,” Clinica Chimica Acta, vol. 314, no. 1-2, pp. 85–91, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Arner, “Genetic variance and lipolysis regulation: implications for obesity,” Annals of Medicine, vol. 33, no. 8, pp. 542–546, 2001. View at Google Scholar · View at Scopus
  15. O. Ukkola, T. Rankinen, S. J. Weisnagel et al., “Interactions among the α2-, β2-, and β3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study,” Metabolism, vol. 49, no. 8, pp. 1063–1070, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Mori, H. Kim-Motoyama, Y. Ito et al., “The Gln27Glu β2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men,” Biochemical and Biophysical Research Communications, vol. 258, no. 1, pp. 138–140, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck, “β2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals,” American Journal of Hypertension, vol. 18, no. 7, pp. 1009–1014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Masuo, T. Katsuya, H. Kawaguchi et al., “β2-Adrenoceptor polymorphisms relate to obesity through blunted leptin mediated sympathetic activation,” American Journal of Hypertension, vol. 19, no. 10, pp. 1084–1091, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Large, L. Hellström, S. Reynisdottir et al., “Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 3005–3013, 1997. View at Google Scholar · View at Scopus
  20. K. Leineweber, R. Büscher, H. Bruck, and O. E. Brodde, “β-Adrenoceptor polymorphisms,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 369, no. 1, pp. 1–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck, “β2- and β3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years,” Circulation, vol. 111, no. 25, pp. 3429–3434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kawaguchi, K. Masuo, T. Katsuya et al., “β2- and β3-adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals,” Hypertension Research, vol. 29, no. 12, pp. 951–959, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. H. Kim, D. J. Kim, I. A. Seo et al., “Significance of β2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects,” Metabolism, vol. 51, no. 7, pp. 833–837, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. A. P. Gjesing, G. Andersen, K. S. Burgdorf et al., “Studies of the associations between functional β2- adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects,” Diabetologia, vol. 50, no. 3, pp. 563–568, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Garenc, L. Pérusse, Y. C. Chagnon et al., “Effects of β2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study,” Obesity Research, vol. 11, no. 5, pp. 612–618, 2003. View at Google Scholar · View at Scopus
  26. T. Hayakawa, Y. Nagai, T. Kahara et al., “Gln27Glu and Arg16Gly polymorphisms of the β2-adrenergic receptor gene are not associated with obesity in Japanese men,” Metabolism, vol. 49, no. 9, pp. 1215–1218, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. V. S. Mattevi, V. M. Zembrzuski, and M. H. Hutz, “Impact of variation in ADRB2, ADRB3, and GNB3 genes on body mass index and waist circumference in a Brazilian population,” American Journal of Human Biology, vol. 18, no. 2, pp. 182–186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. H. Daghestani, A. A. Warsy, M. H. Daghestani et al., “The Gln27Glu polymorphism in β2-adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis,” Lipids in Health and Disease, vol. 9, article 90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Al-Nozha, Y. Y. Al-Mazrou, M. A. Al-Maatouq et al., “Obesity in Saudi Arabia,” Saudi Medical Journal, vol. 26, no. 5, pp. 824–829, 2005. View at Google Scholar · View at Scopus
  30. J. S. Al-Malki, M. H. Al-Jaser, and A. S. Warsy, “Overweight and obesity in Saudi females of childbearing age,” International Journal of Obesity, vol. 27, no. 1, pp. 134–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. S. Warsy and M. A. F. El-Hazmi, “Diabetes mellitus, hypertension and obesity—common multifactorial disorders in Saudis,” Eastern Mediterranean Health Journal, vol. 5, no. 6, pp. 1236–1242, 1999. View at Google Scholar · View at Scopus
  32. M. H. Daghestani, Levels of leptin and reproductive hormones and detection of leptin receptor gene in Saudi Females with Polycystic ovary syndrome [Ph.D. thesis], King Saud University, Zoology Department, 2006.
  33. F. Galletti, R. Iacone, E. Ragone et al., “Lack of association between polymorphism in the β2- adrenergic receptor gene, hypertension, and obesity in the Olivetti Heart Study,” American Journal of Hypertension, vol. 17, no. 8, pp. 718–720, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. P. J. Havel, “Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance,” Proceedings of the Nutrition Society, vol. 59, no. 3, pp. 359–371, 2000. View at Google Scholar · View at Scopus
  36. C. S. Mantzoros and S. J. Moschos, “Leptin: In search of role(s) in human physiology and pathophysiology,” Clinical Endocrinology, vol. 49, no. 5, pp. 551–567, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Google Scholar · View at Scopus
  38. S. Reynisdottir, H. Wahrenberg, K. Carlstrom, S. Rossner, and P. Arner, “Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta2-adrenoceptors,” Diabetologia, vol. 37, no. 4, pp. 428–435, 1994. View at Google Scholar · View at Scopus
  39. J. W. E. Jocken and E. E. Blaak, “Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity,” Physiology and Behavior, vol. 94, no. 2, pp. 219–230, 2008. View at Publisher · View at Google Scholar · View at Scopus